Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis

Recent advances in our understanding of the role of interleukin (IL)-6 in autoimmunity and in particular rheumatoid arthritis (RA) have brought about important changes in the way we think about autoimmune diseases. Encouraging data from several phase III clinical trials of tocilizumab, a humanized m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hushaw, Linda L, Sawaqed, Ray, Sweis, Ghaleb, Reigle, Jori, Gopal, Anjali, Brandt, Daniel, Sweis, Nadia, Curran, James, Niewold, Timothy B, Sweiss, Nadera J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857613/
https://www.ncbi.nlm.nih.gov/pubmed/20421913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857613/
https://www.ncbi.nlm.nih.gov/pubmed/20421913

Ejemplares similares